Study guide
12.2 Analgesics & NSAIDs
MFDS Part 1 Membership of the Faculty of Dental Surgery
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
Current Exam Facts How to Use This Guide Eligibility, Booking & the MFDS Pathway
2 Basic Sciences, History Taking & Clinical Assessment
1.1 Head & Neck Anatomy and Underpinning Basic Sciences 1.2 History Taking, Communication & Clinical Examination 1.3 Special Tests, Investigations & Diagnostic Accuracy 1.4 Differential Diagnosis, Triage & When to Biopsy 1.5 Dental Anomalies & Developmental Conditions
3 Cariology, Operative Dentistry & Endodontics
2.1 Cariology & Caries Diagnosis 2.2 Caries Management & Prevention 2.3 Operative Dentistry & Cavity Preparation 2.4 Endodontics 2.5 Tooth Surface Loss & Tooth Discolouration
4 Periodontology & Prosthodontics
3.1 Periodontology 3.2 Fixed Prosthodontics 3.3 Removable Prosthodontics 3.4 Occlusion & Occlusal Assessment
5 Paediatric Dentistry, Orthodontics & Dental Trauma
4.1 Paediatric Dentistry 4.2 Orthodontics 4.3 Dental Trauma 4.4 Orthodontic Assessment, Indices & Referral 4.5 Impacted Teeth & Radiographic Localisation
6 Oral Surgery, Treatment Planning & Prevention
5.1 Oral Surgery & Extractions 5.2 Treatment Planning & Patient Management 5.3 Prevention & Health Promotion
7 Cardiovascular, Respiratory & Endocrine Disease
6.1 Cardiovascular Disease 6.2 Respiratory Disease 6.3 Endocrine Disease & Diabetes 6.4 Bleeding Disorders & Anticoagulation
8 Haematology, Infection & the Medically Compromised Patient
7.1 Haematology 7.2 Infectious Disease 7.3 The Medically Compromised Patient 7.4 Neurological & Gastrointestinal Disease
9 Medical Emergencies in Dental Practice
8.1 Medical Emergencies & Resuscitation 8.2 Anaphylaxis & Acute Allergy 8.3 Emergency Drugs & the Resuscitation Kit
10 Special Care Dentistry, Mental Health & Anxiety Management
9.1 Special Care Dentistry & Patients with Disability 9.2 Mental Health & Behavioural Science 9.3 Dental Anxiety & Behaviour Management
11 Oral Medicine — Mucosal Disease & Orofacial Pain
10.1 Oral Mucosal Disease & Lichen Planus 10.2 Vesiculobullous & Ulcerative Disorders 10.3 Candidiasis & Fungal Infections 10.4 Orofacial Pain & Neuropathic Disorders
12 Oral Pathology — Lesions, Cysts, Tumours & Salivary Glands
11.1 Premalignant Lesions & Oral Cancer 11.2 Odontogenic Cysts 11.3 Odontogenic & Non-Odontogenic Tumours 11.4 Salivary Gland Disease
13 Pharmacology — Local Anaesthesia, Analgesia & Sedation
12.1 Local Anaesthesia 12.2 Analgesics & NSAIDs 12.3 Conscious Sedation
14 Pharmacology — Antimicrobials, Prescribing & Drug Interactions
13.1 Antimicrobials & Antibiotic Stewardship 13.2 Prescribing & Drug Interactions
15 Dental Materials
14.1 Properties & Testing of Dental Materials 14.2 Amalgam & Metal Restorations 14.3 Composite Resin & Adhesive Dentistry 14.4 Impression Materials, Cements & Other Materials
16 Microbiology, Infection Control & Radiology
15.1 Oral Microbiology & Infection Control 15.2 Dental Radiology & Imaging 15.3 Radiation Protection
17 Law, Ethics, Professionalism & Evidence-Based Dentistry
16.1 Consent & Confidentiality 16.2 GDC Standards & Professionalism 16.3 Safeguarding & Duty of Candour 16.4 Evidence-Based Dentistry & Research Methods 16.5 Records, Information Governance & Regulation 16.6 Communication, Teamworking, Human Factors & Raising Concerns
18 Statistics, Dental Public Health, Critical Appraisal & Exam Strategy
17.1 Statistics & Critical Appraisal 17.2 Dental Public Health & Epidemiology 17.3 SBA Technique & Exam Strategy 17.4 Final Review & Key Points
12.2 Analgesics & NSAIDs
Key Takeaways Explain This Topic AI
Paracetamol acts mainly by central COX inhibition with weak peripheral action; the adult maximum is 4 g per 24 hours, and overdose causes hepatotoxicity treated with intravenous acetylcysteine
NSAIDs inhibit peripheral COX-1 and COX-2, providing anti-inflammatory as well as analgesic effect; key adverse effects are gastrointestinal bleeding, renal impairment, and asthma exacerbation in 5–20% of asthmatics (Samter's triad: asthma, nasal polyps, aspirin sensitivity)
The combination of paracetamol plus ibuprofen is the most effective oral analgesic regimen for acute dental pain, acting via complementary central and peripheral mechanisms
Codeine is a weak opioid pro-drug activated by CYP2D6; tramadol has serotonergic activity and carries a risk of seizures and serotonin syndrome when combined with SSRIs
NSAIDs are contraindicated in active peptic ulcer disease, significant renal impairment, anticoagulant therapy, pregnancy in the third trimester, and infants under 6 months
Last updated: August 2026
Paracetamol
Paracetamol (acetaminophen) is the first-line analgesic for mild-to-moderate dental pain. Its mechanism is primarily central cyclooxygenase (COX) inhibition in the brain and spinal cord, with weak peripheral action. Unlike NSAIDs, it has little anti-inflammatory effect.
- Feature Detail
- Adult dose 500–1000 mg every 4–6 hours, up to 4 g per 24 hours
- Child dose Weight-based (BNF); avoid in hepatatic impairment
- Onset ~30 minutes orally
- Duration 4–6 hours
Key toxicity Hepatotoxicity — centrilobular necrosis; the toxic metabolite NAPQI accumins when glutathione is depleted
Antidote Intravenous acetylcysteine (ideally within 8 hours of overdose)
Paracetamol is generally safe in pregnancy, renal impairment, and with anticoagulants — features that make it attractive for dental patients with comorbidities.
NSAIDs (Non-Steroidal Anti-Inflammatory Drugs)
NSAIDs inhibit peripheral COX-1 and COX-2 , reducing prostaglandin synthesis. This provides analgesic and anti-inflammatory action, making them effective for the inflammatory component of dental pain.
Common Agents in Dental Practice
- Agent Typical Adult Dose Notes
- Ibuprofen 400 mg every 4–6 hours (max 2.4 g/24 h) First-line NSAID; favourable GI safety profile
- Diclofenac 50 mg every 8 hours Effective but higher GI and cardiovascular risk; restricted use in UK
- Naproxen 250–500 mg every 8–12 hours Preferred in patients with cardiovascular disease
- Celecoxib 100–200 mg every 12 hours COX-2 selective ; lower GI risk; higher cardiovascular risk
- Adverse Effects of NSAIDs
Gastrointestinal bleeding — prostaglandin inhibition removes the protective mucus barrier; risk highest in elderly, history of ulcer, and with anticoagulants. Use a proton pump inhibitor (PPI) for at-risk patients.
Renal impairment — prostaglandins maintain renal blood flow; NSAIDs reduce GFR, especially in dehydrated patients, the elderly, and those on ACE inhibitors or diuretics.
Asthma exacerbation — 5–20% of asthmatics experience bronchospasm with NSAIDs. Samter's triad is asthma, nasal polyps, and aspirin/NSAID sensitivity.
Platelet inhibition — reversible COX-1 blockade reduces platelet aggregation; additive with anticoagulants.
Pregnancy — avoided in the third trimester (premature closure of the ductus arteriosus); avoid under 30 weeks unless essential; contraindicated in infants under 6 months.
- NSAID Contraindications Summary
- Active or history of peptic ulcer disease
- Significant renal impairment (eGFR <30)
- Concurrent anticoagulant therapy (warfarin, DOACs)
- Known NSAID-sensitive asthma (Samter's triad)
- Pregnancy third trimester
- Infants under 6 months
- Severe heart failure
- Opioids
Opioids act on mu receptors in the central nervous system. They are used for moderate-to-severe dental pain when paracetamol and NSAIDs are insufficient.
Weak Opioids
Codeine — pro-drug converted by CYP2D6 to morphine (about 5–10%). Poor metabolisers get limited analgesia. Main side effects: constipation, nausea, drowsiness. Useful as co-codamol (codeine + paracetamol).
Dihydrocodeine — similar potency to codeine; 30 mg every 4–6 hours.
Tramadol — 50–100 mg every 4–6 hours. Acts on mu receptors AND enhances serotonergic and noradrenergic pathways. Risk of seizures at high dose; serotonin syndrome when combined with SSRIs, SNRIs, or MAOIs. Avoid in epilepsy and withdrawing patients.
Strong Opioids
Morphine — 10 mg every 4 hours orally; reserved for severe postoperative pain, usually in secondary care.
- Opioid Side Effects
- Respiratory depression (dose-dependent; rare at therapeutic oral doses but important in sedation/elderly)
- Constipation (common with codeine)
- Nausea and vomiting
- Tolerance and dependence with prolonged use
- WHO Analgesic Ladder
The World Health Organization ladder guides stepwise analgesic escalation: Step 3: Strong opioid ± non-opioid ± adjuvant (severe pain)
- ↑
- Step 2: Weak opioid ± non-opioid ± adjuvant (moderate pain)
- ↑
- Step 1: Non-opioid (paracetamol ± NSAID) ± adjuvant (mild pain)
For acute dental pain, most patients need only steps 1 and 2. Postoperative dental pain typically lasts 48–72 hours; prescribe accordingly.
Dental Pain Evidence: Combination Analgesia
For acute dental pain, the most effective oral regimen is paracetamol combined with an NSAID (usually ibuprofen). The two drugs act via complementary central and peripheral mechanisms and produce additive or synergistic pain relief without opioid side effects.
- Regimen Pain Relief (approximate)
- Ibuprofen 400 mg + paracetamol 1000 mg Highest — superior to either alone or to many opioid combinations
- Ibuprofen 400 mg alone Strong
- Paracetamol 1000 mg alone Moderate
- Codeine 60 mg + paracetamol 1000 mg (co-codamol 30/500) Moderate; constipation and nausea common
Practical prescribing after a typical extraction: ibuprofen 400 mg three times daily plus paracetamol 1 g four times daily for 48 hours , then step down as pain allows.
Prescribing Cautions in the Dental Patient
Anticoagulated patients (warfarin, DOACs): paracetamol is safe at standard doses; avoid NSAIDs (additive bleeding and INR effects with warfarin).
Renal impairment : paracetamol safe; NSAIDs avoid or use briefly with monitoring.
Elderly : start low, go slow; NSAID risk (GI, renal, cardiovascular) rises sharply with age.
Pregnancy : paracetamol is first-line and safe; avoid NSAIDs in third trimester; opioids only if essential and short-term.
Breastfeeding : paracetamol and ibuprofen are compatible; codeine is now contraindicated in breastfeeding mothers because ultra-rapid metabolisers expose the infant to morphine via breast milk.